Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Clinical Trials in Canada / NCT01694940
Recruiting Observational

North American Mitochondrial Disease Consortium Patient Registry and Biorepository (NAMDC)

NCT01694940 · tracked via the Priya Life Science Canada tracker
Sponsor
Columbia University
Phase
Observational
Started
2011-01-31
Last updated
2026-02-04

Condition(s) studied

Mitochondrial DisordersMitochondrial Genetic DisordersMitochondrial DiseasesDisorder of Mitochondrial Respiratory Chain ComplexesDeletion and Duplication of Mitochondrial DNA

Study summary

The North American Mitochondrial Disease Consortium (NAMDC) maintains a patient contact registry and tissue biorepository for patients with mitochondrial disorders.

Eligibility

Sex
ALL
Min age
—
Max age
—
Healthy volunteers
Accepted
Inclusion Criteria: * Patients diagnosed with or suspected to have a mitochondrial disorder * Adult carriers of known mitochondrial DNA mutations * Patients with laboratory analysis indicative of a mitochondrial disorder. * Medical information and tissue samples are also accepted from deceased individuals who fulfill the above criteria. Exclusion Criteria: * Patients not suspected of having a mitochondrial disorder * Patients not suspected of carrying a mitochondrial DNA or nuclear DNA mutation that affects mitochondrial function.

Primary outcome measure(s)

  • There is no primary outcome measure for this study — end of study
    This is a registry protocol and therefore there is no primary outcome measure for this study.

Trial sites (17)

FacilityCityRegionStatus
University of California San Diego San Diego California Recruiting
Lucile Packard Children's Hospital Stanford California Recruiting
Children's Hospital of Colorado Aurora Colorado Recruiting
Children's National Medical Center Washington D.C. District of Columbia Recruiting
University of Florida Gainsville Florida Recruiting
Massachusetts General Hospital Boston Massachusetts Recruiting
Mayo Clinic Rochester Minnesota Recruiting
Columbia University Medical Center New York New York Recruiting
Virtual Site (Remote enrollment) New York New York Recruiting
Akron Children's Hospital Akron Ohio Recruiting
Cleveland Clinic Cleveland Ohio Recruiting
Case Western Reserve University Clevland Ohio Recruiting
The Children's Hospital of Philadelphia Philadelphia Pennsylvania Recruiting
Children's Hospital of Pittsburgh Pittsburgh Pennsylvania Recruiting
Baylor College of Medicine Houston Texas Recruiting
Seattle Children's Hospital and Regional Medical Center Seattle Washington Recruiting
McMaster University Hamilton Ontario Recruiting

More Columbia University trials in Canada

A Prospective Natural History Study in Uveal Melanoma Active, not recruiting
Integrated HIV Prevention and HCV Care for PWID Active, not recruiting

Other trials for the same condition

Deoxynucleosides Pyrimidines as Treatment for Mitochondrial Depletion Syndrome Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT01694940 on ClinicalTrials.gov ↗ ← All trials in Canada